WINSTON TAYLOR LLP (FORMERLY KNOWN AS WINSTON & STRAWN LLP) for BARR LABORATORIES INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
authorized generics (H.R. 806; S.1082); patent reform legislation (H.R. 1908 and S.1145); FDA reform and regulation, and the federal drug approval process for generic drugs (S.1082; H.R. 2900); appropriations for the FDA Office of Generic Drug Approval (H.R. 3161; S.1859); procedures for drug approval harmonization in prospective trade agreements. Development of a biogeneric drug approval framework (S.1695; H.R. 1956); Issues affecting pharmaceuticals, including: Settlements legislation, S.316; opposition to legislation proposing patent filing deadline extensions, H.R. 1778 and various Senate amendments;
| Lobbyist | Covered position, as disclosed |
|---|---|
| WESLEY BIZZELL | N/A |
| CHARLES L KINNEY | N/A |
| JOHN D MCMICKLE | N/A |
| JOHN A WAITS | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.